Our dystrophin-deficient strains DP1 and DP2 display altered molecular pathways that are very similar to those observed in mdx mice and DMD patients, strongly implying that this model system phenocopies many aspects of the disease at the molecular level (49–51). This evidence concerns the gene DMD and Duchenne muscular dystrophy.